<DOC>
	<DOCNO>NCT02024464</DOCNO>
	<brief_summary>This clinical trial compare two implantable device intend low pressure inside eye glaucoma patient . One two device implant immediately follow cataract surgery placement posterior chamber intra-ocular lens .</brief_summary>
	<brief_title>Comparing Hydrus Microstent ( TM ) iStent Lowering IOP Glaucoma Patients Undergoing Cataract Surgery ( COMPARE I )</brief_title>
	<detailed_description>This prospective , multicenter , single-masked , randomized clinical trial compare Cataract Extraction ( CE ) + Hydrus Microstent CE surgery + iStent implant reduction intraocular pressure patient positive diagnosis primary open angle glaucoma , pseudoexfoliative glaucoma , pigmentary dispersion glaucoma operable cataract . Eligible patient schedule cataract surgery . At conclusion successful cataract surgery placement posterior-chamber IOL , qualify subject randomize receive either Hydrus Microstent iStent implant . Post-operative follow-up visit conduct regular interval .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>A diagnosis primary open angle glaucoma ( POAG ) , Pseudoexfoliative ( PXG ) glaucoma , Pigmentary dispersion glaucoma ( PDG ) An operable agerelated cataract BCVA 20/40 worse , eligible phacoemulsification . Forms primary secondary glaucoma list Prior glaucoma surgery study eye</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Primary open angle glaucoma</keyword>
	<keyword>POAG</keyword>
	<keyword>Pseudoexfoliative glaucoma</keyword>
	<keyword>PXG</keyword>
	<keyword>Pigmentary dispersion glaucoma</keyword>
	<keyword>PDG</keyword>
	<keyword>Hydrus</keyword>
</DOC>